Clinical Trials List
2018-05-01 - 2021-06-30
Phase II
Recruiting3
ICD-10M32.14
Glomerular disease in systemic lupus erythematosus
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chen Der-Yuan Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- WEN-NAN HUANG Division of Rheumatology
- 黃文男、 陳一銘、 謝祖怡、 林靖才、 謝佳偉、 陳信華、 曾智偉、 周吟怡、 洪維廷 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHENG-HAN WU 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
60 participants
